These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1098907)

  • 1. [Growth hormone and insulin curve following glucose loading in patients with acromegaly].
    Kolaszyński J; Owczarczyk I; Pawlikowski M
    Endokrynol Pol; 1975; 26(3):265-9. PubMed ID: 1098907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma levels of growth hormone and insulin in acromegaly].
    Derot M; Rosselin G; Assan R; Freychet P; Tchobroutsky G
    Ann Endocrinol (Paris); 1966; 27(6):776-83. PubMed ID: 5973131
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly].
    Porzio G; Massara F; Camanni F; Rizzi G; Molinatti GM
    Minerva Med; 1976 Oct; 67(50):3241-2. PubMed ID: 995281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insulin, glucagon and C-peptide content in the blood of acromegaly patients].
    Molitvoslovova NN
    Probl Endokrinol (Mosk); 1983; 29(3):21-4. PubMed ID: 6346317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretin and insulin release in acromegaly.
    Chisholm DJ; Lazarus L; Young JD
    J Clin Endocrinol Metab; 1972 Jul; 35(1):108-12. PubMed ID: 5032508
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of somatotropinemia in patients with acromegaly following administration of L-dopa].
    Chiodini PG; Liuzzi A; Cremascoli G; Botalla L
    Folia Endocrinol; 1973 Dec; 26(6):497-502. PubMed ID: 4801260
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertransferrinemia in acromegaly.
    Misaki M; Takarada Y; Seguchi C
    Horm Metab Res; 1985 Aug; 17(8):425-6. PubMed ID: 3902606
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of beneficial response of serum GH in acromegalic patients treated with medroxyprogesterone acetate (MPA).
    Jackson IM; Ormston BJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):413-5. PubMed ID: 5051364
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine].
    Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A
    Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly.
    Saad MJ; Moreira AC; Foss MC
    Braz J Med Biol Res; 1990; 23(10):953-7. PubMed ID: 2129261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
    Hattori N; Shimatsu A; Kato Y; Koshiyama H; Ishikawa Y; Assadian H; Tanoh T; Nagao M; Imura H
    J Clin Endocrinol Metab; 1990 Mar; 70(3):771-6. PubMed ID: 2106529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressibility of plasma growth hormone levels in acromegaly with dexamethasone and phentolamine.
    Nakagawa K; Mashimo K
    J Clin Endocrinol Metab; 1973 Aug; 37(2):238-46. PubMed ID: 4720071
    [No Abstract]   [Full Text] [Related]  

  • 18. Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate.
    Malarkey WB; Daughaday WH
    J Clin Endocrinol Metab; 1971 Sep; 33(3):424-31. PubMed ID: 4936883
    [No Abstract]   [Full Text] [Related]  

  • 19. [STH blood level after metopirone in 12 patients with acromegaly].
    Chiodini PG; Liuzzi A; Spinelli F; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):431-5. PubMed ID: 4664004
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.